Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CRLS1 Antikörper

CLS Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7132824
  • Target Alle CRLS1 (CLS) Antikörper anzeigen
    CRLS1 (CLS) (Cardiolipin Synthase (CLS))
    Reaktivität
    • 16
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 15
    • 1
    Kaninchen
    Klonalität
    • 16
    Polyklonal
    Konjugat
    • 11
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CRLS1 Antikörper ist unkonjugiert
    Applikation
    • 15
    • 13
    • 10
    • 3
    • 1
    • 1
    Immunohistochemistry (IHC), ELISA
    Kreuzreaktivität
    Human, Maus
    Aufreinigung
    Antigen Affinity Purified
    Immunogen
    Human CRLS1
    Isotyp
    IgG
    Top Product
    Discover our top product CLS Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS with 0.1 % Sodium Azide, 50 % Glycerol, pH 7.3. -20 °C, Avoid freeze / thaw cycles.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CRLS1 (CLS) (Cardiolipin Synthase (CLS))
    Andere Bezeichnung
    CRLS1 (CLS Produkte)
    Hintergrund
    0610009I22Rik antibody, 4930557M15Rik antibody, 5730490M08 antibody, C20orf155 antibody, Cardiolipin synthase 1 antibody, Cardiolipin synthase antibody, CLS antibody, CLS1 antibody, CRLS1 antibody, CRLS1_HUMAN antibody, dJ967N21.6 antibody, GCD10 antibody, OTTMUSP00000016677 antibody, Protein GCD10 homolog antibody, RGD1311037 antibody, RP23-77H16.4 antibody
    UniProt
    Q9UJA2
Sie sind hier:
Kundenservice